Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

11.1%

1 terminated/withdrawn out of 9 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

5(83.3%)

Phase 1

1(16.7%)

6Total

N/A(5)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT05454371Not ApplicableWithdrawn

Investigation of Urinary Biomarkers for the Detection of Prostate Cancer

Role: lead

NCT05453604Not ApplicableUnknown

Evaluation Protocols for Isolation of Analytes From Urine for Future Oncology Applications

Role: lead

NCT05453591Not ApplicableUnknown

Investigation of Urinary Biomarkers for the Detection of Breast Cancer

Role: lead

NCT04530201Not ApplicableCompleted

CASUS: Validation for Detection of Precursor Lesions

Role: collaborator

NCT04480866Not ApplicableCompleted

CASUS: Improved and Quality Assured Collection of First-void Urine

Role: collaborator

NCT02552914Completed

Evaluation of the Use of the Colli-Pee Device to Collect First-void Urine for Molecular Detection of STIs

Role: collaborator

NCT02727114Completed

Echographic Measurement of Skin Thickness in Children

Role: lead

NCT02186977Phase 1Completed

Proof Of Concept : Immunogenicity and Safety of hepB Injection in the Dermis Using VAX-ID

Role: lead

NCT02363465Completed

Echographic Measurement of Skin Thickness

Role: lead

All 9 trials loaded